ATF-2 Double Nickase Plasmid (h): sc-416662-NIC
- Target species: human
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- ATF-2 Double Nickase Plasmid (h) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
- Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
- One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
- ATF-2 Double Nickase Plasmid (h) and ATF-2 Double Nickase Plasmid (h2) encode distinct paired gRNA designs targeting ATF2. One or both designs may be available
- Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: ATF-2 Antibody (F2BR-1): sc-242
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
ATF-2 Double Nickase Plasmid (h) | sc-416662-NIC | 20 µg | $410.00 | |||
ATF-2 Double Nickase Plasmid (h2) | sc-416662-NIC-2 | 20 µg | $410.00 |
ATF2 encodes activating transcription factor 2 (ATF-2), a bZIP transcription factor that forms homo- or heterodimers with AP-1 family members to regulate stimulus-responsive gene expression. ATF-2 is activated by phosphorylation downstream of stress-activated MAPK pathways, including JNK and p38, linking extracellular stress, DNA damage signaling, and inflammatory cues to transcriptional programs controlling proliferation, apoptosis, and differentiation. Through modulation of cytokine expression, cell-cycle regulators, and chromatin-associated processes, ATF-2 influences cellular adaptation to oxidative and genotoxic stress. Dysregulated ATF-2 activity has been implicated in oncogenic signaling, metastatic behavior, and altered immune or stress responses, making it relevant for mechanistic studies of tumor biology and stress pathway rewiring.
ATF-2 Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the ATF2 locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within ATF2. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt ATF2 function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.
To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of ATF2-disrupted clones.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.